UB Paderborn / Katalog / Suche / in CDI

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

Lancet neurology, 2003-12, Vol.2 (12), p.731-740

2003

Volltextzugriff (PDF)

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

The Lancet (British edition), 2011-08, Vol.378 (9791), p.595-605

2011

Volltextzugriff (PDF)

Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration

Scientific reports, 2018-05, Vol.8 (1), p.8398-20, Article 8398

2018

Volltextzugriff (PDF)

MyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro : protocols and their applications

Frontiers in physiology, 2023-05, Vol.14, p.1145047-1145047

2023

Volltextzugriff (PDF)

A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5215

2023

Volltextzugriff (PDF)

A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples

PloS one, 2018-03, Vol.13 (3), p.e0194540-e0194540

2018

Volltextzugriff (PDF)

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy

Journal of cachexia, sarcopenia and muscle, 2022-04, Vol.13 (2), p.1360-1372

2022

Volltextzugriff (PDF)

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan

eLife, 2020-09, Vol.9

2020

Volltextzugriff (PDF)

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Acta neuropathologica communications, 2021-01, Vol.9 (1), p.7-7, Article 7

2021

Volltextzugriff (PDF)

ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies

Brain (London, England : 1878), 2013, Vol.136 (Pt 1), p.269-281

2013

Volltextzugriff (PDF)

Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases

Frontiers in physiology, 2021-10, Vol.12, p.716471-716471

2021

Volltextzugriff (PDF)

A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies

Acta neuropathologica communications, 2020-04, Vol.8 (1), p.53-53, Article 53

2020

Volltextzugriff (PDF)

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy

Molecular therapy. Methods & clinical development, 2020-09, Vol.18, p.415-421

2020

Volltextzugriff (PDF)

Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy

Annals of neurology, 2006-11, Vol.60 (5), p.603-610

2006

Volltextzugriff (PDF)

Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies

PloS one, 2013-07, Vol.8 (7), p.e68958-e68958

2013

Volltextzugriff (PDF)

Defective glycosylation in muscular dystrophy

The Lancet (British edition), 2002-11, Vol.360 (9343), p.1419-1421

2002

Volltextzugriff (PDF)

Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy

Human molecular genetics, 2005-03, Vol.14 (5), p.657-665

2005

Volltextzugriff (PDF)

Irradiation dependent inflammatory response may enhance satellite cell engraftment

Scientific reports, 2020-07, Vol.10 (1), p.11119, Article 11119

2020

Volltextzugriff (PDF)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation

Molecular genetics and metabolism reports, 2016-06, Vol.7 (C), p.55-62

2016

Volltextzugriff (PDF)

Muscular Dystrophies Due to Glycosylation Defects

Neurotherapeutics, 2008-10, Vol.5 (4), p.627-632

2008

Volltextzugriff (PDF)

Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy

Molecular therapy, 2012-02, Vol.20 (2), p.462-467

2012

Volltextzugriff (PDF)

Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle

Neuromuscular disorders : NMD, 2003, Vol.13 (1), p.21-31

2003

Volltextzugriff (PDF)

Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies

Current opinion in neurology, 2011-10, Vol.24 (5), p.437-442

2011

Volltextzugriff (PDF)

Refining genotype–phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan

Brain (London, England : 1878), 2007-10, Vol.130 (10), p.2725-2735

2007

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration

Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling

MyoD-induced reprogramming of human fibroblasts and urinary stem cells in vitro : protocols and their applications

A Proof of Principle Proteomic Study Detects Dystrophin in Human Plasma: Implications in DMD Diagnosis and Clinical Monitoring

A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies

Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases

A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy

Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy

Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies

Defective glycosylation in muscular dystrophy

Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy

Irradiation dependent inflammatory response may enhance satellite cell engraftment

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation

Muscular Dystrophies Due to Glycosylation Defects

Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy

Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle

Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies

Refining genotype–phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan

Suchergebnisse filtern